163 related articles for article (PubMed ID: 21342787)
1. 5-HT(4) receptors, a place in the sun: act two.
Bockaert J; Claeysen S; Compan V; Dumuis A
Curr Opin Pharmacol; 2011 Feb; 11(1):87-93. PubMed ID: 21342787
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic potential of serotonin 4 receptor for chronic depression and its associated comorbidity in the gut.
Agrawal L; Korkutata M; Vimal SK; Yadav MK; Bhattacharyya S; Shiga T
Neuropharmacology; 2020 Apr; 166():107969. PubMed ID: 31982703
[TBL] [Abstract][Full Text] [Related]
3. Involvement of 5-HT3 and 5-HT4 receptors in colonic motor patterns in rats.
Yu Y; Chen JH; Li H; Yang Z; Du X; Hong L; Liao H; Jiang L; Shi J; Zhao L; Tan S; Luo H; Huizinga JD
Neurogastroenterol Motil; 2015 Jul; 27(7):914-28. PubMed ID: 25807879
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and pharmacological properties of novel hydrophilic 5-HT4 receptor antagonists.
Brudeli B; Moltzau LR; Andressen KW; Krobert KA; Klaveness J; Levy FO
Bioorg Med Chem; 2010 Dec; 18(24):8600-13. PubMed ID: 21075638
[TBL] [Abstract][Full Text] [Related]
5. Serotonin-enhanced hyperactivation of hamster sperm.
Fujinoki M
Reproduction; 2011 Aug; 142(2):255-66. PubMed ID: 21555358
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of 5-HT4 receptor enhances differentiation of mouse induced pluripotent stem cells into neural progenitor cells.
Ishizuka T; Goshima H; Ozawa A; Watanabe Y
Clin Exp Pharmacol Physiol; 2014 May; 41(5):345-50. PubMed ID: 24606396
[TBL] [Abstract][Full Text] [Related]
7. 5-HT(4) receptors: history, molecular pharmacology and brain functions.
Bockaert J; Claeysen S; Compan V; Dumuis A
Neuropharmacology; 2008 Nov; 55(6):922-31. PubMed ID: 18603269
[TBL] [Abstract][Full Text] [Related]
8. Discovery, oral pharmacokinetics and in vivo efficacy of velusetrag, a highly selective 5-HT(4) receptor agonist that has achieved proof-of-concept in patients with chronic idiopathic constipation.
Long DD; Armstrong SR; Beattie DT; Choi SK; Fatheree PR; Gendron RA; Genov D; Goldblum AA; Humphrey PP; Jiang L; Marquess DG; Shaw JP; Smith JA; Turner SD; Vickery RG
Bioorg Med Chem Lett; 2012 Oct; 22(19):6048-52. PubMed ID: 22959244
[TBL] [Abstract][Full Text] [Related]
9. Modulation of hippocampal excitability by 5-HT4 receptor agonists persists in a transgenic model of Alzheimer's disease.
Spencer JP; Brown JT; Richardson JC; Medhurst AD; Sehmi SS; Calver AR; Randall AD
Neuroscience; 2004; 129(1):49-54. PubMed ID: 15489027
[TBL] [Abstract][Full Text] [Related]
10. Design of fluorinated 5-HT(4)R antagonists: influence of the basicity and lipophilicity toward the 5-HT(4)R binding affinities.
Fontenelle CQ; Wang Z; Fossey C; Cailly T; Linclau B; Fabis F
Bioorg Med Chem; 2013 Dec; 21(23):7529-38. PubMed ID: 24128816
[TBL] [Abstract][Full Text] [Related]
11. Study of 5HT3 and HT4 receptor expression in HT29 cell line and human colon adenocarcinoma tissues.
Ataee R; Ajdary S; Rezayat M; Shokrgozar MA; Shahriari S; Zarrindast MR
Arch Iran Med; 2010 Mar; 13(2):120-5. PubMed ID: 20187666
[TBL] [Abstract][Full Text] [Related]
12. Acidic biphenyl derivatives: synthesis and biological activity of a new series of potent 5-HT(4) receptor antagonists.
Brudeli B; Andressen KW; Moltzau LR; Nilsen NO; Levy FO; Klaveness J
Bioorg Med Chem; 2013 Nov; 21(22):7134-45. PubMed ID: 24113240
[TBL] [Abstract][Full Text] [Related]
13. Serotonin 5-HT3 and 5-HT4 ligands: an update of medicinal chemistry research in the last few years.
Modica MN; Pittalà V; Romeo G; Salerno L; Siracusa MA
Curr Med Chem; 2010; 17(4):334-62. PubMed ID: 20015043
[TBL] [Abstract][Full Text] [Related]
14. An aqueous extract of Poncirus fructus activates the prokinetic activity of 5-HT receptor subtype 4 without hERG interaction.
Shim WS; Back H; Jung SW; Kim JW; Jang Y; Lee B; Seo EK; Oh U; Shim CK
J Ethnopharmacol; 2010 Oct; 132(1):328-33. PubMed ID: 20736054
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic modulators of the serotonin 5-HT
Lanthier C; Dallemagne P; Lecoutey C; Claeysen S; Rochais C
Expert Opin Ther Pat; 2020 Jul; 30(7):495-508. PubMed ID: 32400221
[TBL] [Abstract][Full Text] [Related]
16. The Serotonin 4 Receptor Subtype: A Target of Particular Interest, Especially for Brain Disorders.
Sgambato V
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791281
[TBL] [Abstract][Full Text] [Related]
17. Modifications of 5-HT4 receptor expression in rat brain during memory consolidation.
Manuel-Apolinar L; Rocha L; Pascoe D; Castillo E; Castillo C; Meneses A
Brain Res; 2005 Apr; 1042(1):73-81. PubMed ID: 15823255
[TBL] [Abstract][Full Text] [Related]
18. Effect of chronic pain on morphine-induced respiratory depression in mice.
Kamei J; Ohsawa M; Hayashi SS; Nakanishi Y
Neuroscience; 2011 Feb; 174():224-33. PubMed ID: 21081158
[TBL] [Abstract][Full Text] [Related]
19. Investigations on 5-HT₄ receptor expression and effects of tegaserod on human platelet aggregation in vitro.
Serebruany VL; El Mouelhi M; Pfannkuche HJ; Rose K; Marro M; Angiolillo DJ
Am J Ther; 2010; 17(6):543-52. PubMed ID: 19797939
[TBL] [Abstract][Full Text] [Related]
20. Cardiovascular effects of metoclopramide and domperidone on human 5-HT
Neumann J; Seidler T; Fehse C; Marušáková M; Hofmann B; Gergs U
Eur J Pharmacol; 2021 Jun; 901():174074. PubMed ID: 33811834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
